The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models
新型 CXCR4 拮抗剂 PRX177561 可减少胶质母细胞瘤临床前模型中的肿瘤细胞增殖并加速癌症干细胞分化
期刊:Tumor Biology
影响因子:
doi:10.1177/1010428317695528
Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, Flora Vitale, Antonella Vetuschi, Simona Pompili, Giulia Rossi, Francesco Marampon, Peter J Richardson, Lee Patient, Lee Patient, Stephen Burbidge, Claudio Festuccia
